EvolutionaryScale
AI research lab developing frontier models for protein design and biological discovery.
About
EvolutionaryScale provides Frontier AI for the life sciences, offering ESM3, a language model that enables scientists to understand, imagine, and create proteins. Their latest innovation, ESM Cambrian, sets a new state of the art for protein sequence modeling and representation learning. The company serves scientists seeking to design novel proteins for applications such as new medicines, carbon capture, and plastic degradation.
Key facts
- Website
- evolutionaryscale.ai
- Headquarters
- New York City, United States
- Founded
- 2023
- Employees
- 28
- Total funding
- $142M (Seed)
- Valuation
- Private
- Business model
- B2B
- Tags
- AIBiotechnologySaaSLife Sciences TechNeoLab
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 25 Jun 2024 | Seed | $142M | Nat Friedman, Daniel Gross, Lux Capital |
Tech stack
Detected on evolutionaryscale.ai, last scanned 19 Sept 2026. Run your own scan
- Analytics
- Google Analytics 4
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Google Workspace
Frequently asked
How much funding has EvolutionaryScale raised?
EvolutionaryScale has raised a total of $142M in funding. The most recent round on record is Seed.
How many employees does EvolutionaryScale have?
EvolutionaryScale has approximately 28 people on record.